As a follow up to the successful BIOMEDevice—An MD&M Event, in San Jose, California, CANON COMMUNICATIONS introduced another event on the East Coast to serve the heavily concentrated medical device and biopharma markets in Massachusetts and its immediate surrounding area. The BIOMEDevice—An MD&M Event exposition and executive forum will return for its second year on April 21-22, 2010 at the Boston Convention Center.

The relative shows make sense in a business environment where California and Massachusetts have attracted a combined 60% of the $58 billion in medical devices and biotechnology venture capital in the U.S. during the past decade. Further underscoring this is the Life Sciences Law approved by the Massachusetts state legislature last June, containing $1 billion in capital, tax incentives, and bond issues.

Sponsored by the Massachusetts Medical Device Industry Council (MassMEDIC), the BIOMEDevice exposition will include 300 leading suppliers to the medical device and biopharma industry, while the BIOMEDevice forum will focus on convergence and cross-sector collaborations among companies in the biotechnology, medical device, IVD, and pharmaceutical industries. This premier executive level forum brings together key players involved in investing, partnering, licensing, and developing business opportunities in the rapidly growing market for innovative healthcare products. Agenda topics will include the latest technologies, designs, manufacturing methods, testing protocols, and FDA regulations and compliance procedures for new drug-device combinations, drug-delivery systems, molecular diagnostics, sophisticated imaging systems, and other advances that are shaping next-generation disease detection and treatment—as well as the future of the medical device industry.

The BIOMEDevice audience is thousands of medical design and manufacturing professionals, biopharma development and manufacturing professionals, and senior executives focused on new product innovation and development.

Show Floor Features include: